Inventor · disambiguated record
Kevin A. Goncalves
Also filed as: GONCALVES KEVIN · GONCALVES KEVIN A
2 granted patents·13 pending applications·8 citations·filing 2016–2024
54Inventor score
Top patents by PatentIndex Score
15 records- 0186US10058573B1Dosing regimens for the mobilization of hematopoietic stem cellsMAGENTA THERAPEUTICS INC·Filed 2017·Granted Aug 28, 2018·7 cites·9 claims
- 0279US2025295698A1Dosing regimens for the mobilization of hematopoietic stem cellsENSOMA INC·Filed 2024·Application pending·0 cites
- 0377US11260079B2Dosing regimens for the mobilization of hematopoietic stem and progenitor cellsMAGENTA THERAPEUTICS INC·Filed 2019·Granted Mar 1, 2022·1 cites·23 claims
- 0473US2025032549A1Dosing regimens for the mobilization of hematopoietic stem and progenitor cellsENSOMA INC·Filed 2024·Application pending·0 cites
- 0572US2023130646A1Dosing regimens for the mobilization of hematopoietic stem cellsMAGENTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0668US2021179625A1Aryl hydrocarbon receptor antagonists and uses thereofMAGENTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0763US2022096559A1Dosing regimens for the mobilization of hematopoietic stem and progenitor cellsMAGENTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0860US2019336536A1Dosing regimens for the mobilization of hematopoietic stem and progenitor cellsMAGENTA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0956US2023330185A1Methods and compositions for transducing hematopoietic stem and progenitor cells in vivoMAGENTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1056US2019167726A1Dosing Regimens for the Mobilization of Hematopoietic Stem CellsMAGENTA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1152US2022401481A1Dosing regimens for the mobilization of hematopoietic stem and progenitor cellsMAGENTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1247US2020338132A1Compositions and methods for the expansion of hematopoietic stem and progenitor cells and treatment of inherited metabolic disordersMAGENTA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1344US2019314407A1Compositions and methods for the expansion of hematopoietic stem and progenitor cellsMAGENTA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1441US2021220408A1Aryl hydrocarbon receptor antagonists and methods of useMAGENTA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1533US2019000885A1Treatment with angiogenin to enhance hematopoietic reconstitutionMASSACHUSETTS GEN HOSPITAL·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →